The Inaugural Rocky Mountain Life Science Investor Conference Welcomes 31 Investors

Share Article

The Inaugural Rocky Mountain Life Science Investor Conference (RMLIC) will bring 31 life science investors and business development professionals to Denver in order to showcase the talent and research being conducted in the Rocky Mountain region. The conference will include 30 regional company presentations, panel discussions on venture capital and business development, and keynote presentations from both Dr. Tom Cech and Roy Davis, President of Johnson & Johnson Corporate Development/Corporate Venturing.

On Thursday, September 17, Denver will welcome 31 life science investors and business development professionals for the inaugural Rocky Mountain Life Science Investor Conference. This conference will showcase 30 of the region's top life science companies to interested investors including business development professionals from large pharmaceutical, biotechnology, medical device and diagnostic companies.

"We are excited to welcome over 30 of the life science community's most renowned investors to the inaugural Rocky Mountain Life Science Investor Conference," said John Collar, President and CEO of the Colorado BioScience Association. "This will allow Colorado and the Rocky Mountain region to offer an inside look into the innovation and talent that lies in this region, and we can't wait to see the partnerships and connections made during this conference."

The 31 Investor firms and companies attending to date for the September 17 Conference include:

o Amgen,
o Bay City Capital,
o Boulder Ventures,
o Celgene,
o Chart Life Sciences
o Clovis Oncology
o Covidien,
o Frazier Healthcare Ventures,
o Genentech,
o H.I.G. Ventures,
o High Country Ventures,
o Hunt BioVentures,
o Johnson & Johnson,
o Keld, LLC,
o KRG Capital Partners,
o Lilly Ventures,
o Mesa Verde Venture Partners,
o Morgenthaler Ventures,
o NovaQuest
o Novartis Venture Fund,
o Prairiegold Ventures,
o Puente Partners
o Red Script,
o Rocky Mountain Venture Capital Association,
o Sequel Ventures,
o Skyline Ventures,
o Sun Mountain Capital,
o Technology Partners,
o Telegraph Hill Partners,
o vSpring Capital,
o Yasuda Enterprise Development,

The organizers for the RMLIC have previously chosen 30 companies to provide 20 minute presentations on their innovation and business plan in order to garner interest amongst the attending investors. Companies and life science entrepreneurs within the region that are not presenting during the conference also have the opportunity to attend the event and schedule private partnering time with investors.

The presenting companies include:

Allogenesis, Denver, CO; Apoplogic, Aurora, CO; Applied Microarrays, Inc., Tempe, AZ; Axial Biotech, Salt Lake City, UT; Beacon Biotechnology, Aurora, CO; BioAmps, Aurora, CO; Biodesix, Broomfield, CO; BiOptix, Boulder, CO; Castle Biosciences, Phoenix, AZ; Coherex, Salt Lake City, UT; GlobeImmune, Louisville, CO; High Throughput Genomics, Tucson, AZ; Inviragen, Fort Collins, CO; Kinetic Muscles, Tempe, AZ; Leap Frogg, Grand Junction, CO; LigoCyte Pharmaceuticals, Bozeman, MT; LineaGen, Salt Lake City, UT; Medipacs, Tucson, AZ; Medivance, Louisville, CO; miRagen, Boulder, CO; Myocept, Lafayette, CO; NanoMR, Albuquerque, NM; Numira Biosciences, Salt Lake City, UT; PharmaJet, Golden, CO; Regenesis, Scottsdale, AZ; SenesTech, Inc., Flagstaff, AZ; Thermimage, Salt Lake City, UT; ValveXchange, Aurora, CO; Vital Access, Salt Lake City, UT; Western States Biopharmaceuticals, Aurora, CO.

"This conference will be an excellent forum for emerging companies to showcase their capabilities and for investors to witness the critical ingredients of Colorado's successful bioscience community." J. William Freytag, Ph.D., former President and CEO of Myogen, says.
For registration information, visit the conference website at

About Arizona BioIndustry Association
The Arizona BioIndustry Association is a not-for-profit, 501(c)(6) trade association that seeks to unify, empower and advance its member organizations, allowing them to benefit individually by acting collectively. AZBio strives to enhance the environment that makes Arizona a place where bioscience companies can grow and succeed. AZBio is the state affiliate in Arizona for the Biotechnology Industry Organization (BIO), the preeminent trade association for the biotechnology industry in the United States. For more information, visit

About Colorado BioScience Association

CBSA is a not-for-profit corporation providing services and support for Colorado's growing biosciences industry. With more than 400 members, the CBSA actively works to promote the growth of the industry by advocating for a better business environment, by promoting programs that grow the state's bioscience workforce, by fighting for policies that support a strong bioscience industry in the state and by speaking with a single voice on behalf of the companies in the state. For more information, visit

April Giles, Vice President, Administration & Operations, Colorado BioScience Association, 303-592-4071

Leah Kientz, Director of Public Policy and Programs, Colorado BioScience Association - 303-592-4088

Maggie Chamberlin Holben, APR, Absolutely PR - - 303-984-9801


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website